Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Long-term follow-up of patients on drug holiday from bisphosphonates: real-world setting.

Chiha M, Myers LE, Ball CA, Sinacore JM, Camacho PM.

Endocr Pract. 2013 Nov-Dec;19(6):989-94. doi: 10.4158/EP12425.OR.

PMID:
24013976
[PubMed - in process]
2.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

PMID:
23074491
[PubMed]
Free PMC Article
3.

Effects of a 'drug holiday' on bone mineral density and bone turnover marker during bisphosphonate therapy.

Kong SY, Kim DY, Han EJ, Park SY, Yim CH, Kim SH, Yoon HK.

J Bone Metab. 2013 May;20(1):31-5. doi: 10.11005/jbm.2013.20.1.31. Epub 2013 May 13.

PMID:
24524053
[PubMed]
Free PMC Article
4.

Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.

Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.

J Clin Endocrinol Metab. 2001 Jul;86(7):3079-85.

PMID:
11443170
[PubMed - indexed for MEDLINE]
5.

Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.

Sebba AI.

Clin Ther. 2008 Mar;30(3):443-52. doi: 10.1016/j.clinthera.2008.03.008. Review. Erratum in: Clin Ther. 2008 Jun;30(6):1177-8.

PMID:
18405784
[PubMed - indexed for MEDLINE]
6.
7.

Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G.

Clin Endocrinol (Oxf). 2000 Mar;52(3):319-27.

PMID:
10718830
[PubMed - indexed for MEDLINE]
8.

Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.

Krieg MA, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiébaud D, Burckhardt P.

Osteoporos Int. 2001;12(2):112-6.

PMID:
11303710
[PubMed - indexed for MEDLINE]
9.

Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.

Cortet B, Béra-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B.

Joint Bone Spine. 2001 Oct;68(5):410-5.

PMID:
11707007
[PubMed - indexed for MEDLINE]
10.

A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.

Thornton J, Ashcroft D, O'Neill T, Elliott R, Adams J, Roberts C, Rooney M, Symmons D.

Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. Review.

PMID:
18284894
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy.

Lim JS, Jin SH, Kim SB, Lee JI.

J Clin Gastroenterol. 2012 Sep;46(8):669-74. doi: 10.1097/MCG.0b013e31824f1af4.

PMID:
22504799
[PubMed - indexed for MEDLINE]
12.

Osteoporosis prevention clinical study program.

Delmas P, Gimona A.

Eur J Obstet Gynecol Reprod Biol. 1996 Apr;64 Suppl:S39-45.

PMID:
8732473
[PubMed - indexed for MEDLINE]
13.

Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.

Rahim A, Holmes SJ, Adams JE, Shalet SM.

Clin Endocrinol (Oxf). 1998 Apr;48(4):463-9.

PMID:
9640413
[PubMed - indexed for MEDLINE]
14.

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women.

Bruyere O, Varela AR, Adami S, Detilleux J, Rabenda V, Hiligsmann M, Reginster JY.

Eur J Epidemiol. 2009;24(11):707-12. doi: 10.1007/s10654-009-9381-4. Epub 2009 Aug 29.

PMID:
19728118
[PubMed - indexed for MEDLINE]
15.

Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy.

Kostoff MD, Saseen JJ, Borgelt LM.

Int J Womens Health. 2014 Apr 28;6:423-8. doi: 10.2147/IJWH.S57549. eCollection 2014.

PMID:
24855392
[PubMed]
Free PMC Article
16.

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.

Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.

J Bone Miner Res. 1998 Sep;13(9):1431-8.

PMID:
9738515
[PubMed - indexed for MEDLINE]
17.

Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.

PMID:
15647969
[PubMed - indexed for MEDLINE]
18.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

PMID:
18088161
[PubMed - indexed for MEDLINE]
Free Article
19.

Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.

Frediani B, Bertoldi I, Pierguidi S, Nicosia A, Picerno V, Filippou G, Cantarini L, Galeazzi M.

Clin Drug Investig. 2013 Mar;33(3):193-8. doi: 10.1007/s40261-013-0062-4.

PMID:
23456672
[PubMed - indexed for MEDLINE]
20.

Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis.

Orr-Walker B, Wattie DJ, Evans MC, Reid IR.

Clin Endocrinol (Oxf). 1997 Jan;46(1):87-92.

PMID:
9059563
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk